34 filings
Page 2 of 2
8-K
8zx9 l3nt
5 Aug 21
Codiak BioSciences Reports Second Quarter 2021 Financial Results and Operational Progress
4:08pm
8-K
t2er1 jcca8
6 Jul 21
Departure of Directors or Certain Officers
5:01pm
8-K
o7cul0sz jlxej9lx
23 Jun 21
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
p35imw60n7sdw7mhpf
20 May 21
Departure of Directors or Certain Officers
5:00pm
8-K
n7bh3fw06bni7zy2w9ji
10 May 21
Codiak Appoints Jennifer Wheler, M.D., as Chief Medical Officer
5:18pm
8-K
0nggj0 03153
6 May 21
Codiak BioSciences Reports First Quarter 2021 Financial Results and Operational Progress
4:10pm
8-K
iugp pxez9usn
8 Apr 21
Regulation FD Disclosure
4:05pm
8-K
hv9oh8 v275
26 Mar 21
Departure of Directors or Certain Officers
4:05pm
8-K
52kl5c4dylnj
17 Mar 21
Codiak BioSciences Reports Fourth Quarter and Full Year 2020 Financial Results
7:44am
8-K
yeaz6bi56 m4dvtx0
8 Mar 21
Departure of Directors or Certain Officers
5:18pm
8-K
6i7knwk8 1etmp50
4 Feb 21
Codiak Reports Additional Positive Phase 1 Results for exoIL-12™ Confirming
8:46am
8-K
6e7 g92alei9q1314i1
26 Jan 21
Departure of Directors or Certain Officers
4:39pm
8-K
3lffh 8f5pnxm9loioo
30 Dec 20
Codiak Reports Positive Initial Phase 1 Results for exoIL-12™ Demonstrating Tolerability and Absence of Systemic IL-12 Exposure in Healthy Volunteers
8:00am
8-K
o388vz 84nchl7frohd
20 Nov 20
Codiak BioSciences Reports Third Quarter 2020 Financial Results and Operational Progress
4:32pm